Jenny Robertson serves as Executive at Lexeo Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jenny Robertson has executed 6 insider transactions totaling $39.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 18, 2025 involved selling 549 shares valued at $5.1K.
Jenny Robertson currently holds 68,381 shares of Lexeo Therapeutics, Inc. (LXEO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jenny Robertson has been a net seller of LXEO stock. They have purchased $0 and sold $39.2K worth of shares.
Jenny Robertson's most recent insider trade was on Nov 18, 2025, when they sold 549 shares at $9.27 per share.
Get notified when new Form 4 filings are submitted
| $8.94 |
| Discretionary |
| Oct 17, 2025 | LXEO | $382 | Sale | 40 | $9.56 | Discretionary |
| Oct 15, 2025 | LXEO | $0 | Award | 9,900 | $N/A | Discretionary |
| Aug 18, 2025 | LXEO | $2.5K | Sale | 542 | $4.67 | Discretionary |
| Jan 5, 2024 | LXEO | $0 | Award | 23,750 | $N/A | Planned |